Delay in development EU portal for clinical research with a medicinal product

The European Medicines Agency (EMA) has reported that the development of the web portal, under construction for the implementation of EU Regulation 536/2014 for clinical research with a medicinal product, has been delayed. It is not yet known if this will have an effect on the date of delivery of the EU portal. Further explanation and decision-making on the possible consequences will take place at the meeting of the EMA Management Board on 14 and 15 June 2017.